Pre-Clinical/Clinical

Raw materials can be a major source of variability, affecting development and manufacturing. This conference provides strategies for developing a comprehensive raw material variability testing, characterization and control plan.

New technologies and risk mitigation strategies to detect, prevent and remediate viral contaminations in raw materials, cell culture processes and facilities throughout the entire supply chain.

AsiaTIDES continues to be the premier forum to get a comprehensive update, meet key players and increase your knowledge of the oligonucleotide- and peptide-based therapeutics fields. The best forum to gain applied and basic knowledge, build your collaborative network, and learn skills to move your projects forward in one of today’s hottest research areas.

Attend this conference to hear biobetter development strategies and biosimilar comparability studies from Centocor, Teva, Xencor, Amunix, Ambrx, Aegis, Antares, Macrogenics, Bayer, Biogen Idec, AnaptysBio, PharmaEssentia, Eureka, Amgen, Johnson & Johnson, Simcere, and more!

More Information: http://www.chinapharmard.com

TIDES® remains THE place to meet all the important players in oligonucleotide and peptide therapeutics and diagnostic development and manufacturing, as well as raw material and equipment supply - and now discovery too.

Oligonucleotide Therapeutics Discovery, co-located with the TIDES Summit, is designed to provide discovery, preclinical and early development scientists with strategies to accelerate lead generation, improve drug-like properties and select the best oligonucleotide candidates for development.

Peptide Discovery & Development is a unique program that focuses exclusively on innovations in peptide design, discovery, selection and delivery with an emphasis on strategies to exploit protein-protein interactions, find new peptide-like molecular scaffolds and develop intracellular peptides to access previously "undruggable targets" and disease mechanisms.

Navigate FDA's evolving regulatory requirements to successfully achieve market approval or clearance for novel molecular technologies. Understand the latest developments in personalized medicine and companion diagnostics, and how new technologies including next generation sequencing will transform molecular diagnostics. Update your knowledge on analytical methods and validation.

A comprehensive update on novel scaffolds and preclinical/clinical data and lessons learned. A part of Next Generation Protein Therapeutics Summit.